Pomerantz LLP

Please review this complaint. Click to Contact Us about joining this ACTION >>

Questions? Ask Us

The Chemours Company

We are investigating The Chemours Company (CC) (“Chemours” or the “Company”) for potential violations of the federal securities laws. 

On August 1, 2019, Chemours disclosed its financial results for the second quarter of 2019.  The Company’s earnings missed estimated by a wide margin, and revenues fell 22.5% year-to-year to $1.41 billion, prompting Chemours to cut its full-year earnings guidance.  Chemours described the quarter as “challenging on a number of fronts, including softer than expected Ti-Pure demand and the continued impact of illegal imports of HFC refrigerants into Europe.”  On this news, Chemours’s stock price fell $3.47 per share, or 19.11%, to close at $14.69 per share on August 2, 2019.